Publications by authors named "Koby Mok"

Claim this Profile
I
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis.
Enrique Alvarez, Lawrence Steinman, Edward J Fox, Hans-Peter Hartung, Peiqing Qian, Koby Mok

Front Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Koby Mok

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.
Edward Fox, Amy E Lovett-Racke, Matthew Gormley, Yue Liu, Maria Petracca, Koby Mok

Mult Scler· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gonadal steroid regulation of renal injury in renal wrap hypertension.
Hong Ji, Stefano Menini, Koby Mok, Wei Zheng, Carlo Pesce

Am J Physiol Renal Physiol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis